Newsletter | November 11, 2026

11.11.26 -- My CDMO Is A Constellation Of Unified Skills. Is Yours?

SPONSOR

Webinar: Mitigating risk across the OSD lifecycle: How expert CDMO partnership can build early foundations for long-term success

Early development decisions can make or break an oral solid dosage (OSD) program. Join experts from Bora Pharmaceuticals and Corealis Pharma to explore how risk management, Quality by Design, and CDMO partnerships improve scalability, streamline technology transfer, and protect product quality. Learn how to identify challenges early and support commercialization. Click here to learn more.

INDUSTRY INSIGHTS

Winning Strategies For Commercial Manufacturing Leaders

Complex formulations, HPAPIs, and modified-release products demand early planning. Formulation strategy, tech transfer, infrastructure, and partner selection largely determine scale-up success.

The Growing Strategic Importance Of U.S. Pharmaceutical Manufacturing

Pharma manufacturing strategy now extends beyond cost and capacity, with resilience, flexibility, alignment, and market proximity supporting lasting success.

Powder Rheology: Gateway For Tablet Sticking Insights

Powder rheology offers a scientific method to predict and mitigate tablet sticking issues, helping to ensure smoother pharmaceutical production cycles through early material and tooling selection.

FEATURED EDITORIAL

My CDMO Is A Constellation Of Unified Skills. Is Yours?

A CDMO employs accomplished professionals, operates modern facilities, and still frustrates the heck out of you. Accumulated talent and capabilities are impressive, but closer examination reveals the problem lies between the lines of the CDMO’s work demarcations. Instead, you need your CDMO to operate as a constellation of unified skills. Chief Editor Louis Garguilo explores this "holistic pattern of work that forms an interconnected organization, and presents a clear picture of management and culture."

Expanding Global Access Through Voluntary Licensing And Tech Transfer

Turning patented biomedical discoveries into affordable, widely available treatments requires aligned partnerships between innovator pharma and regional generic manufacturers. In this episode of Outsourcing Against the Outbreak, Charles Gore, Executive Director of the Medicines Patent Pool (MPP), breaks down how voluntary licensing models expand access across low- and middle-income markets.

INDUSTRY INSIGHTS CONTINUED

The Art of Formulation

Explore how Altasciences integrates pharmaceutical formulation development with nonclinical research to optimize drug formulations, assess risks, and support progression to FIH trials.

De-Risking Complex Generic OSD Development

Complex generic tablet development requires early alignment of regulatory strategy, QbD formulation, discriminatory dissolution, and reference-scaled bioequivalence.

Seamless Commercial Tech Transfers In OSD Manufacturing

A structured approach to OSD tech transfer, from NPI through PPQ and CPV, can compress timelines significantly, as one case study illustrates with full PPQ completion in under six months.

Continuous Manufacturing For API Breakthroughs

Observe how a compound library, designed for chemical diversity and lead-like properties, uses advanced filtering to improve hit discovery, speed hit-to-lead development, and boost drug discovery.

Using Continuous Manufacturing To Accelerate OSD Commercialization

Hear firsthand insights on the company’s first OSD product submission enabled by continuous manufacturing and Real-Time Release Testing.

Choosing The Best Amorphous Dispersion Path Before It Costs You

Parallel screening across multiple solid dispersion platforms early optimizes drug solubility and stability, building a strong technical foundation that prevents costly development delays.

From Powder To Particles With Jet Milling

Gain valuable insights into the jet milling process and Quality by Design approach for inhalation drug delivery and their potential applications in drug development.

SOLUTIONS

Solid Oral Dose Formulation And Manufacturing Services

Quality Drive + People Powered

Supporting Your ADCs With Proven Payload And Linker Manufacturing

Fine Chemical Manufacturing Services: R&D From Concept To Commercial

Sterile Drug Product Development And Manufacturing

OUTSOURCED PHARMA CAPABILITIES UPDATE

Find Your New CDMO At Outsourced Pharma Capabilities Update

CDMOs in biologics, cell and gene, and small molecule share their capabilities and available capabilities. See for yourself why this virtual event has become a wildly popular resource to identify options for your development and manufacturing needs.

Connect With Outsourced Pharma: